Overview

Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis

Status:
COMPLETED
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
A Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis
Phase:
PHASE4
Details
Lead Sponsor:
The Dermatology Institute of Boston